Tirzepatide staying a dual GLP-1 and GIP agonist, it is actually suggested which the GIP part of dual agonism could possibly be chargeable for the extra advantage, provided the prospective advantage of GIP receptor agonism on peripheral insulin sensitization. Consequently, tirzepatide was simpler than dulaglutide in lessening fasting dietary TAG [